No use of empiric antimicrobial therapy, n
|
21 |
18 |
In cases of no BSI, n/N (%) |
18/21 (86) |
18/18 (100) |
In cases of BSI, n/N (%) |
3/21 (14) |
0/18 (0) |
Empiric antimicrobial therapy, n
|
19 |
22 |
In cases of no BSI, n/N (%) |
8/19 (42) |
8/22 (36) |
In cases of BSI, n/N (%) |
11/19 (58) |
14/22 (64) |
Empiric coverage for Gram-negative organism, n
|
18 |
15 |
In cases of no Gram-negative BSI, n/N (%) |
12/18 (67) |
8/15 (53) |
In cases of Gram-negative BSI, n/N (%) |
6/18 (33) |
7/15 (47) |
Empiric coverage for Gram-positive BSI, n
|
13 |
7 |
In cases of no Gram-positive BSI, n/N (%) |
10/13 (77) |
2/7 (29) |
In cases of Gram-positive BSI, n/N (%) |
3/13 (23) |
5/7 (71) |